Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker ALKS
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 3, 2026 | David Joseph Gaffin EVP, CLO, Alkermes, Inc. | ALKS Alkermes plc | Sale | 2,035 | $46.17 | $94.0K Sale | Form 4 ↗ |
| Sep 3, 2026 | David Joseph Gaffin EVP, CLO, Alkermes, Inc. | ALKS Alkermes plc | Sale | 2,034 | $48.01 | $97.7K Sale | Form 4 ↗ |
| Sep 1, 2026 | Craig C. Hopkinson EVP R&D, Chief Medical Officer | ALKS Alkermes plc | Sale | 9,000 | $46.99 | $422.9K Sale | Form 4 ↗ |
| Aug 17, 2026 | Christian Todd Nichols SVP, Chief Commercial Officer | ALKS Alkermes plc | Sale | 664 | $49.65 | $33.0K Sale | Form 4 ↗ |
| Aug 17, 2026 | Christian Todd Nichols SVP, Chief Commercial Officer | ALKS Alkermes plc | Sale | 6,912 | $49.19 | $340.0K Sale | Form 4 ↗ |
| Aug 3, 2026 | nancy lynn snyderman MD Director | ALKS Alkermes plc | Sale | 44,472 | $50.35 | $2.2M Sale | Form 4 ↗ |
| Aug 3, 2026 | Craig C. Hopkinson EVP R&D, Chief Medical Officer | ALKS Alkermes plc | Sale | 9,000 | $48.58 | $437.2K Sale | Form 4 ↗ |
| Aug 3, 2026 | David Joseph Gaffin EVP, CLO, Alkermes, Inc. | ALKS Alkermes plc | Sale | 2,034 | $48.58 | $98.8K Sale | Form 4 ↗ |
| Jul 6, 2026 | David Joseph Gaffin EVP, CLO, Alkermes, Inc. | ALKS Alkermes plc | Sale | 2,034 | $54.03 | $109.9K Sale | Form 4 ↗ |
| Jul 1, 2026 | Craig C. Hopkinson EVP R&D, Chief Medical Officer | ALKS Alkermes plc | Sale | 700 | $52.13 | $36.5K Sale | Form 4 ↗ |
| Jul 1, 2026 | Craig C. Hopkinson EVP R&D, Chief Medical Officer | ALKS Alkermes plc | Sale | 8,300 | $51.46 | $427.1K Sale | Form 4 ↗ |
| Jun 12, 2026 | Christopher I. Wright Director | ALKS Alkermes plc | Sale | 2,000 | $45.10 | $90.2K Sale | Form 4 ↗ |
| Jun 4, 2026 | David Joseph Gaffin EVP, CLO, Alkermes, Inc. | ALKS Alkermes plc | Sale | 2,034 | $43.05 | $87.6K Sale | Form 4 ↗ |
| Jun 1, 2026 | Craig C. Hopkinson EVP R&D, Chief Medical Officer | ALKS Alkermes plc | Sale | 9,000 | $41.67 | $375.0K Sale | Form 4 ↗ |
| May 29, 2026 | Samuel Joseph Parisi VP, Finance (Interim PAO) | ALKS Alkermes plc | Sale | 16,217 | $42.36 | $687.0K Sale | Form 4 ↗ |
| May 4, 2026 | David Joseph Gaffin EVP, CLO, Alkermes, Inc. | ALKS Alkermes plc | Sale | 2,034 | $33.20 | $67.5K Sale | Form 4 ↗ |
| May 1, 2026 | Craig C. Hopkinson EVP R&D, Chief Medical Officer | ALKS Alkermes plc | Sale | 9,000 | $33.40 | $300.6K Sale | Form 4 ↗ |
| Apr 6, 2026 | David Joseph Gaffin EVP, CLO, Alkermes, Inc. | ALKS Alkermes plc | Sale | 2,034 | $34.57 | $70.3K Sale | Form 4 ↗ |
| Apr 1, 2026 | Craig C. Hopkinson EVP R&D, Chief Medical Officer | ALKS Alkermes plc | Sale | 9,000 | $35.51 | $319.6K Sale | Form 4 ↗ |
| Mar 3, 2026 | David Joseph Gaffin EVP, CLO, Alkermes, Inc. | ALKS Alkermes plc | Sale | 2,034 | $29.76 | $60.5K Sale | Form 4 ↗ |
| Mar 2, 2026 | Samuel Joseph Parisi VP, Finance (Interim PAO) | ALKS Alkermes plc | Sale | 6,890 | $29.29 | $201.8K Sale | Form 4 ↗ |
| Mar 2, 2026 | Christian Todd Nichols SVP, Chief Commercial Officer | ALKS Alkermes plc | Sale | 6,000 | $30.00 | $180.0K Sale | Form 4 ↗ |
| Mar 2, 2026 | Craig C. Hopkinson EVP R&D, Chief Medical Officer | ALKS Alkermes plc | Sale | 9,000 | $29.72 | $267.5K Sale | Form 4 ↗ |
| Mar 2, 2026 | David Joseph Gaffin EVP, CLO, Alkermes, Inc. | ALKS Alkermes plc | Sale | 2,034 | $29.29 | $59.6K Sale | Form 4 ↗ |
| Feb 2, 2026 | Craig C. Hopkinson EVP R&D, Chief Medical Officer | ALKS Alkermes plc | Sale | 4,000 | $33.54 | $134.2K Sale | Form 4 ↗ |
| Feb 2, 2026 | Craig C. Hopkinson EVP R&D, Chief Medical Officer | ALKS Alkermes plc | Sale | 5,000 | $34.24 | $171.2K Sale | Form 4 ↗ |
| Feb 2, 2026 | Shane Cooke Director | ALKS Alkermes plc | Sale | 32,113 | $34.78 | $1.1M Sale | Form 4 ↗ |
| Feb 2, 2026 | Shane Cooke Director | ALKS Alkermes plc | Sale | 29,087 | $34.34 | $998.8K Sale | Form 4 ↗ |
| Jan 8, 2026 | Craig C. Hopkinson EVP R&D, Chief Medical Officer | ALKS Alkermes plc | Sale | 5,000 | $30.00 | $150.0K Sale | Form 4 ↗ |
| Jan 2, 2026 | Craig C. Hopkinson EVP R&D, Chief Medical Officer | ALKS Alkermes plc | Sale | 4,000 | $28.00 | $112.0K Sale | Form 4 ↗ |
| Dec 3, 2025 | Craig C. Hopkinson EVP R&D, Chief Medical Officer | ALKS Alkermes plc | Sale | 3,748 | $30.00 | $112.4K Sale | Form 4 ↗ |
| Dec 1, 2025 | Craig C. Hopkinson EVP R&D, Chief Medical Officer | ALKS Alkermes plc | Sale | 4,000 | $29.30 | $117.2K Sale | Form 4 ↗ |
| Nov 3, 2025 | Craig C. Hopkinson EVP R&D, Chief Medical Officer | ALKS Alkermes plc | Sale | 9,000 | $30.38 | $273.4K Sale | Form 4 ↗ |
| Oct 15, 2025 | Craig C. Hopkinson EVP R&D, Chief Medical Officer | ALKS Alkermes plc | Sale | 9,000 | $31.53 | $283.8K Sale | Form 4 ↗ |
| Jun 10, 2025 | Christian Todd Nichols SVP, Chief Commercial Officer | ALKS Alkermes plc | Sale | 3,334 | $31.09 | $103.7K Sale | Form 4 ↗ |
| Jun 9, 2025 | Christian Todd Nichols SVP, Chief Commercial Officer | ALKS Alkermes plc | Sale | 3,333 | $31.95 | $106.5K Sale | Form 4 ↗ |
| Feb 28, 2025 | Samuel Joseph Parisi VP, Finance (Interim PAO) | ALKS Alkermes plc | Sale | 1,938 | $34.00 | $65.9K Sale | Form 4 ↗ |
| Feb 25, 2025 | Samuel Joseph Parisi VP, Finance (Interim PAO) | ALKS Alkermes plc | Sale | 3,743 | $35.26 | $132.0K Sale | Form 4 ↗ |
| Feb 20, 2025 | Samuel Joseph Parisi VP, Finance (Interim PAO) | ALKS Alkermes plc | Sale | 1,327 | $35.69 | $47.4K Sale | Form 4 ↗ |
| Feb 13, 2025 | Craig C. Hopkinson EVP R&D, Chief Medical Officer | ALKS Alkermes plc | Sale | 108,833 | $36.02 | $3.9M Sale | Form 4 ↗ |
| Feb 13, 2025 | Craig C. Hopkinson EVP R&D, Chief Medical Officer | ALKS Alkermes plc | Sale | 35,586 | $34.02 | $1.2M Sale | Form 4 ↗ |
| Feb 12, 2025 | Craig C. Hopkinson EVP R&D, Chief Medical Officer | ALKS Alkermes plc | Sale | 33,108 | $33.27 | $1.1M Sale | Form 4 ↗ |
| Feb 12, 2025 | Craig C. Hopkinson EVP R&D, Chief Medical Officer | ALKS Alkermes plc | Sale | 171,813 | $32.69 | $5.6M Sale | Form 4 ↗ |
| Jan 30, 2025 | Craig C. Hopkinson EVP R&D, Chief Medical Officer | ALKS Alkermes plc | Sale | 100,918 | $32.05 | $3.2M Sale | Form 4 ↗ |
| Dec 9, 2024 | Craig C. Hopkinson EVP R&D, Chief Medical Officer | ALKS Alkermes plc | Sale | 61,151 | $32.07 | $2.0M Sale | Form 4 ↗ |
| Dec 9, 2024 | Cato T. Laurencin Director | ALKS Alkermes plc | Sale | 2,691 | $31.85 | $85.7K Sale | Form 4 ↗ |
| Dec 5, 2024 | Craig C. Hopkinson EVP R&D, Chief Medical Officer | ALKS Alkermes plc | Sale | 9,221 | $31.50 | $290.5K Sale | Form 4 ↗ |
| Dec 4, 2024 | Craig C. Hopkinson EVP R&D, Chief Medical Officer | ALKS Alkermes plc | Sale | 14,349 | $30.77 | $441.5K Sale | Form 4 ↗ |
| Nov 27, 2024 | Christian Todd Nichols SVP, Chief Commercial Officer | ALKS Alkermes plc | Sale | 5,208 | $29.15 | $151.8K Sale | Form 4 ↗ |
| Nov 11, 2024 | Craig C. Hopkinson EVP R&D, Chief Medical Officer | ALKS Alkermes plc | Sale | 58,996 | $30.08 | $1.8M Sale | Form 4 ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 6:07 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances